|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
TISSUE-SPECIFIC STEM CELLS |
1 Department of Pediatrics, UT Southwestern Medical Center at Dallas
2 Department of Pharmacology, UT Southwestern Medical Center at Dallas
3 Department of Pharmacology; Green Center for Reproductive Biology Sciences; Howard Hughes Medical Institute; UT Southwestern Medical Center at Dallas
* To whom correspondence should be addressed. E-mail: Christina.Dann{at}UTSouthwestern.edu.
| Abstract |
|---|
The long-term production of billions of spermatozoa relies on the regulated proliferation and differentiation of spermatogonial stem cells (SSCs). To date only a few factors are known to function in SSCs to provide this regulation. OCT4 plays a critical role in pluripotency and cell survival of embryonic stem cells and primordial germ cells; however, it is not known whether it plays a similar function in SSCs. Here, we show that OCT4 is required for SSC maintenance in culture, and for colonization activity following cell transplantation, using lentiviral-mediated shRNA expression to knock down OCT4 in an in vitro model for SSCs (germline stem or GS cells). Expression of PLZF, a factor known to be required for SSC self renewal, was not affected by OCT4 knockdown, suggesting that OCT4 does not function upstream of PLZF. In addition to developing a method to test specific gene function in GS cells, we demonstrate that retinoic acid (RA) triggers GS cells to shift to a differentiated, pre-meiotic state lacking OCT4 and PLZF expression and colonization activity. Our data support a model in which OCT4 and PLZF maintain SSCs in an undifferentiated state, and RA triggers spermatogonial differentiation through the direct or indirect down-regulation of OCT4 and PLZF. The current study has important implications for the future use of GS cells as an in vitro model for spermatogonial stem cell biology or as a source of embryonic stem-like cells.
______________________________________________________________________________
Author contributions: C.D.: Conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, final approval of manuscript; A.A.: Collection and/or assembly of data; L.M.: Collection and/or assembly of data; B.D.: Collection and/or assembly of data; D.G.: Financial support; M.P.: Financial support, manuscript writing, experimental design.
Key Words. Spermatogonia, OCT4, Pou5f1, RNAi, Retinoic acid, Stem cell transplantation
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
